Spain · Delayed Price · Currency is EUR Clínica Baviera Statistics
Total Valuation
Clínica Baviera has a market cap or net worth of EUR 945.95 million. The enterprise value is 966.42 million.
| Market Cap | 945.95M |
| Enterprise Value | 966.42M |
Important Dates
The next estimated earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
Clínica Baviera has 16.03 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 16.03M |
| Shares Outstanding | 16.03M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 9.50% |
| Float | 2.69M |
Valuation Ratios
The trailing PE ratio is 20.55.
| PE Ratio | 20.55 |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 8.43 |
| P/TBV Ratio | 13.43 |
| P/FCF Ratio | 20.42 |
| P/OCF Ratio | 12.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.88, with an EV/FCF ratio of 20.86.
| EV / Earnings | 21.03 |
| EV / Sales | 3.01 |
| EV / EBITDA | 10.88 |
| EV / EBIT | 14.96 |
| EV / FCF | 20.86 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.64.
| Current Ratio | 0.94 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 0.80 |
| Debt / FCF | 1.54 |
| Interest Coverage | 24.69 |
Financial Efficiency
Return on equity (ROE) is 45.93% and return on invested capital (ROIC) is 35.34%.
| Return on Equity (ROE) | 45.93% |
| Return on Assets (ROA) | 16.92% |
| Return on Invested Capital (ROIC) | 35.34% |
| Return on Capital Employed (ROCE) | 34.31% |
| Weighted Average Cost of Capital (WACC) | 7.86% |
| Revenue Per Employee | 159,619 |
| Profits Per Employee | 22,872 |
| Employee Count | 2,009 |
| Asset Turnover | 1.34 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Clínica Baviera has paid 17.98 million in taxes.
| Income Tax | 17.98M |
| Effective Tax Rate | 27.75% |
Stock Price Statistics
The stock price has increased by +28.63% in the last 52 weeks. The beta is 0.73, so Clínica Baviera's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +28.63% |
| 50-Day Moving Average | 58.44 |
| 200-Day Moving Average | 53.02 |
| Relative Strength Index (RSI) | 45.67 |
| Average Volume (20 Days) | 1,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Clínica Baviera had revenue of EUR 320.67 million and earned 45.95 million in profits. Earnings per share was 2.87.
| Revenue | 320.67M |
| Gross Profit | 159.84M |
| Operating Income | 64.58M |
| Pretax Income | 64.78M |
| Net Income | 45.95M |
| EBITDA | 88.77M |
| EBIT | 64.58M |
| Earnings Per Share (EPS) | 2.87 |
Balance Sheet
The company has 51.59 million in cash and 71.42 million in debt, with a net cash position of -19.82 million or -1.24 per share.
| Cash & Cash Equivalents | 51.59M |
| Total Debt | 71.42M |
| Net Cash | -19.82M |
| Net Cash Per Share | -1.24 |
| Equity (Book Value) | 112.21M |
| Book Value Per Share | 6.96 |
| Working Capital | -4.03M |
Cash Flow
In the last 12 months, operating cash flow was 77.15 million and capital expenditures -30.83 million, giving a free cash flow of 46.32 million.
| Operating Cash Flow | 77.15M |
| Capital Expenditures | -30.83M |
| Depreciation & Amortization | 24.19M |
| Net Borrowing | -10.02M |
| Free Cash Flow | 46.32M |
| FCF Per Share | 2.89 |
Margins
Gross margin is 49.85%, with operating and profit margins of 20.14% and 14.33%.
| Gross Margin | 49.85% |
| Operating Margin | 20.14% |
| Pretax Margin | 20.20% |
| Profit Margin | 14.33% |
| EBITDA Margin | 27.68% |
| EBIT Margin | 20.14% |
| FCF Margin | 14.45% |
Dividends & Yields
This stock pays an annual dividend of 1.57, which amounts to a dividend yield of 2.68%.
| Dividend Per Share | 1.57 |
| Dividend Yield | 2.68% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 52.82% |
| Buyback Yield | 0.04% |
| Shareholder Yield | 2.72% |
| Earnings Yield | 4.86% |
| FCF Yield | 4.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Clínica Baviera has an Altman Z-Score of 5.49 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.49 |
| Piotroski F-Score | 7 |